Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endovascular Procedures | 241 | 2024 | 2183 | 38.540 |
Why?
|
Aortic Aneurysm, Abdominal | 183 | 2024 | 1228 | 36.890 |
Why?
|
Blood Vessel Prosthesis Implantation | 166 | 2024 | 1428 | 32.760 |
Why?
|
Endarterectomy, Carotid | 67 | 2024 | 555 | 17.550 |
Why?
|
Carotid Stenosis | 72 | 2024 | 860 | 17.160 |
Why?
|
Stents | 128 | 2024 | 3179 | 13.440 |
Why?
|
Vascular Surgical Procedures | 74 | 2024 | 1489 | 12.540 |
Why?
|
Aortic Rupture | 44 | 2024 | 319 | 12.360 |
Why?
|
Peripheral Arterial Disease | 62 | 2024 | 1273 | 10.210 |
Why?
|
Aortic Aneurysm, Thoracic | 28 | 2024 | 696 | 8.530 |
Why?
|
Lower Extremity | 44 | 2024 | 1202 | 7.820 |
Why?
|
Blood Vessel Prosthesis | 47 | 2024 | 951 | 7.700 |
Why?
|
Femoral Artery | 40 | 2024 | 826 | 7.470 |
Why?
|
Ischemia | 45 | 2024 | 1883 | 7.420 |
Why?
|
Angioplasty | 31 | 2021 | 355 | 6.830 |
Why?
|
Carotid Artery Diseases | 28 | 2024 | 877 | 6.770 |
Why?
|
Postoperative Complications | 124 | 2024 | 15633 | 5.610 |
Why?
|
Stroke | 79 | 2024 | 9758 | 5.310 |
Why?
|
Treatment Outcome | 320 | 2024 | 64684 | 5.230 |
Why?
|
Vascular Grafting | 15 | 2019 | 162 | 5.100 |
Why?
|
Time Factors | 240 | 2024 | 39970 | 5.040 |
Why?
|
Risk Factors | 306 | 2024 | 74213 | 4.820 |
Why?
|
Intermittent Claudication | 19 | 2023 | 304 | 4.700 |
Why?
|
Registries | 92 | 2024 | 8224 | 4.360 |
Why?
|
Risk Assessment | 160 | 2024 | 23996 | 4.320 |
Why?
|
Aorta, Thoracic | 16 | 2024 | 1096 | 4.310 |
Why?
|
Angioplasty, Balloon | 21 | 2023 | 589 | 4.020 |
Why?
|
Catheterization, Peripheral | 14 | 2024 | 343 | 3.940 |
Why?
|
Retrospective Studies | 277 | 2024 | 80646 | 3.870 |
Why?
|
Chi-Square Distribution | 70 | 2022 | 3416 | 3.860 |
Why?
|
Spinal Cord Ischemia | 7 | 2023 | 94 | 3.720 |
Why?
|
Vascular System Injuries | 9 | 2024 | 246 | 3.680 |
Why?
|
Thoracic Injuries | 9 | 2024 | 288 | 3.410 |
Why?
|
Aged, 80 and over | 202 | 2024 | 58986 | 3.290 |
Why?
|
Endoleak | 19 | 2023 | 111 | 3.170 |
Why?
|
Limb Salvage | 32 | 2024 | 481 | 3.150 |
Why?
|
Wounds, Nonpenetrating | 10 | 2024 | 807 | 3.140 |
Why?
|
Databases, Factual | 87 | 2024 | 7967 | 3.120 |
Why?
|
Hospital Mortality | 60 | 2024 | 5293 | 3.040 |
Why?
|
Quality Indicators, Health Care | 23 | 2024 | 1792 | 2.960 |
Why?
|
Aged | 317 | 2024 | 169310 | 2.930 |
Why?
|
Aortic Diseases | 12 | 2024 | 735 | 2.820 |
Why?
|
Popliteal Artery | 13 | 2022 | 310 | 2.630 |
Why?
|
United States | 174 | 2024 | 72335 | 2.540 |
Why?
|
Patient Selection | 42 | 2023 | 4244 | 2.470 |
Why?
|
Prosthesis Design | 27 | 2024 | 2115 | 2.340 |
Why?
|
Aneurysm | 7 | 2022 | 337 | 2.210 |
Why?
|
Odds Ratio | 60 | 2020 | 9646 | 2.100 |
Why?
|
Male | 325 | 2024 | 360842 | 2.070 |
Why?
|
Reoperation | 34 | 2024 | 4303 | 2.010 |
Why?
|
Multivariate Analysis | 62 | 2018 | 12059 | 2.000 |
Why?
|
Humans | 455 | 2024 | 761572 | 1.980 |
Why?
|
Female | 326 | 2024 | 392686 | 1.950 |
Why?
|
Aorta, Abdominal | 12 | 2020 | 625 | 1.930 |
Why?
|
Logistic Models | 67 | 2020 | 13255 | 1.910 |
Why?
|
Health Status Disparities | 13 | 2024 | 1852 | 1.890 |
Why?
|
Blood Loss, Surgical | 10 | 2020 | 638 | 1.800 |
Why?
|
Eligibility Determination | 3 | 2021 | 421 | 1.650 |
Why?
|
Mesenteric Vascular Occlusion | 4 | 2019 | 92 | 1.650 |
Why?
|
Medicare | 36 | 2024 | 6770 | 1.600 |
Why?
|
Healthcare Disparities | 18 | 2021 | 3358 | 1.600 |
Why?
|
Decision Support Techniques | 10 | 2021 | 1998 | 1.590 |
Why?
|
Subclavian Artery | 2 | 2024 | 133 | 1.560 |
Why?
|
Ischemic Attack, Transient | 10 | 2024 | 882 | 1.560 |
Why?
|
Protamines | 3 | 2021 | 112 | 1.560 |
Why?
|
Aortography | 11 | 2023 | 421 | 1.550 |
Why?
|
Middle Aged | 195 | 2024 | 220920 | 1.490 |
Why?
|
Iliac Aneurysm | 5 | 2021 | 37 | 1.470 |
Why?
|
Blood Transfusion | 9 | 2022 | 1301 | 1.470 |
Why?
|
Learning Curve | 4 | 2024 | 230 | 1.450 |
Why?
|
Saphenous Vein | 5 | 2020 | 516 | 1.420 |
Why?
|
Thromboembolism | 3 | 2022 | 995 | 1.410 |
Why?
|
Quality Improvement | 15 | 2021 | 3801 | 1.400 |
Why?
|
Retroperitoneal Space | 4 | 2022 | 170 | 1.360 |
Why?
|
Vascular Patency | 27 | 2024 | 911 | 1.350 |
Why?
|
Credentialing | 2 | 2020 | 116 | 1.310 |
Why?
|
Cardiovascular Agents | 7 | 2022 | 840 | 1.310 |
Why?
|
Punctures | 12 | 2024 | 366 | 1.280 |
Why?
|
Aortic Aneurysm | 5 | 2024 | 648 | 1.220 |
Why?
|
Peripheral Vascular Diseases | 9 | 2022 | 488 | 1.190 |
Why?
|
Patient Readmission | 11 | 2024 | 3271 | 1.190 |
Why?
|
Clinical Competence | 11 | 2024 | 4793 | 1.180 |
Why?
|
Propensity Score | 14 | 2023 | 1913 | 1.150 |
Why?
|
Kaplan-Meier Estimate | 34 | 2024 | 6484 | 1.140 |
Why?
|
Aneurysm, Ruptured | 4 | 2022 | 464 | 1.110 |
Why?
|
Vascular Diseases | 5 | 2022 | 1161 | 1.090 |
Why?
|
Wound Healing | 9 | 2024 | 2805 | 1.090 |
Why?
|
Blood Grouping and Crossmatching | 2 | 2017 | 100 | 1.090 |
Why?
|
Diabetes Mellitus | 7 | 2024 | 5841 | 1.080 |
Why?
|
Radiography, Interventional | 3 | 2018 | 1121 | 1.080 |
Why?
|
Sex Factors | 26 | 2024 | 10553 | 1.070 |
Why?
|
Length of Stay | 32 | 2024 | 6426 | 1.070 |
Why?
|
Asymptomatic Diseases | 16 | 2024 | 588 | 1.070 |
Why?
|
Leg | 7 | 2013 | 1088 | 1.060 |
Why?
|
Renal Artery | 5 | 2017 | 351 | 1.050 |
Why?
|
Postoperative Hemorrhage | 3 | 2020 | 415 | 1.050 |
Why?
|
Veins | 7 | 2022 | 768 | 1.000 |
Why?
|
Specialization | 5 | 2022 | 778 | 1.000 |
Why?
|
Arterial Occlusive Diseases | 9 | 2020 | 748 | 0.990 |
Why?
|
Patient Discharge | 10 | 2023 | 3443 | 0.990 |
Why?
|
Arteries | 8 | 2023 | 1123 | 0.980 |
Why?
|
Myocardial Infarction | 32 | 2024 | 11461 | 0.950 |
Why?
|
Graft Occlusion, Vascular | 8 | 2019 | 537 | 0.940 |
Why?
|
Wound Infection | 2 | 2017 | 246 | 0.920 |
Why?
|
Ultrasonography, Interventional | 4 | 2019 | 1496 | 0.910 |
Why?
|
Emergencies | 6 | 2021 | 1217 | 0.900 |
Why?
|
Renal Insufficiency, Chronic | 6 | 2024 | 2243 | 0.890 |
Why?
|
Heparin Antagonists | 2 | 2020 | 34 | 0.880 |
Why?
|
Predictive Value of Tests | 27 | 2021 | 15266 | 0.880 |
Why?
|
Mesenteric Artery, Superior | 4 | 2018 | 96 | 0.880 |
Why?
|
Carotid Arteries | 9 | 2023 | 941 | 0.880 |
Why?
|
Practice Guidelines as Topic | 12 | 2024 | 7391 | 0.870 |
Why?
|
Unnecessary Procedures | 2 | 2017 | 415 | 0.870 |
Why?
|
Renal Dialysis | 6 | 2024 | 1796 | 0.850 |
Why?
|
Glomerular Filtration Rate | 4 | 2024 | 2177 | 0.840 |
Why?
|
Proportional Hazards Models | 29 | 2018 | 12463 | 0.830 |
Why?
|
Mass Screening | 8 | 2024 | 5428 | 0.830 |
Why?
|
Carotid Artery, Common | 3 | 2023 | 175 | 0.830 |
Why?
|
Angiography | 6 | 2023 | 1595 | 0.810 |
Why?
|
Embolization, Therapeutic | 9 | 2020 | 1418 | 0.800 |
Why?
|
Retreatment | 12 | 2021 | 598 | 0.790 |
Why?
|
Age Factors | 30 | 2024 | 18398 | 0.770 |
Why?
|
Chronic Disease | 17 | 2024 | 9319 | 0.750 |
Why?
|
Groin | 2 | 2019 | 106 | 0.750 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2021 | 3245 | 0.730 |
Why?
|
Device Removal | 4 | 2021 | 630 | 0.730 |
Why?
|
Embolism | 3 | 2023 | 399 | 0.720 |
Why?
|
Comorbidity | 24 | 2021 | 10508 | 0.720 |
Why?
|
Endarterectomy | 9 | 2017 | 196 | 0.710 |
Why?
|
Balloon Occlusion | 2 | 2020 | 125 | 0.700 |
Why?
|
Kidney Diseases | 5 | 2022 | 2091 | 0.690 |
Why?
|
Clinical Enzyme Tests | 1 | 2020 | 113 | 0.690 |
Why?
|
Liver Cirrhosis | 2 | 2021 | 1935 | 0.690 |
Why?
|
Hypoglycemic Agents | 4 | 2024 | 3085 | 0.670 |
Why?
|
Paclitaxel | 7 | 2022 | 1732 | 0.650 |
Why?
|
Product Surveillance, Postmarketing | 6 | 2020 | 452 | 0.620 |
Why?
|
Splanchnic Circulation | 2 | 2018 | 119 | 0.620 |
Why?
|
Aspartate Aminotransferases | 1 | 2020 | 416 | 0.610 |
Why?
|
Survival Rate | 22 | 2020 | 12725 | 0.600 |
Why?
|
Amaurosis Fugax | 1 | 2017 | 7 | 0.600 |
Why?
|
Anemia | 2 | 2017 | 1509 | 0.590 |
Why?
|
Liver Circulation | 1 | 2018 | 159 | 0.590 |
Why?
|
Insulin | 4 | 2024 | 6597 | 0.590 |
Why?
|
Recurrence | 24 | 2024 | 8466 | 0.580 |
Why?
|
Health Care Costs | 6 | 2024 | 3242 | 0.570 |
Why?
|
Boston | 14 | 2017 | 9326 | 0.570 |
Why?
|
Platelet Count | 1 | 2020 | 781 | 0.560 |
Why?
|
Prosthesis-Related Infections | 3 | 2022 | 487 | 0.550 |
Why?
|
Imaging, Three-Dimensional | 4 | 2018 | 4063 | 0.550 |
Why?
|
Hepatic Artery | 1 | 2018 | 232 | 0.550 |
Why?
|
Renal Artery Obstruction | 4 | 2016 | 219 | 0.540 |
Why?
|
Platelet Aggregation Inhibitors | 8 | 2024 | 2751 | 0.530 |
Why?
|
Radiation Dosage | 3 | 2023 | 1958 | 0.530 |
Why?
|
Carotid Artery, Internal | 4 | 2024 | 445 | 0.530 |
Why?
|
Pacemaker, Artificial | 1 | 2022 | 807 | 0.520 |
Why?
|
Hospitals | 6 | 2022 | 3882 | 0.520 |
Why?
|
Specialties, Surgical | 2 | 2018 | 389 | 0.520 |
Why?
|
Ehlers-Danlos Syndrome | 3 | 2024 | 93 | 0.520 |
Why?
|
Databases as Topic | 8 | 2011 | 473 | 0.510 |
Why?
|
Hospital Costs | 2 | 2020 | 947 | 0.500 |
Why?
|
Fluoroscopy | 4 | 2023 | 947 | 0.500 |
Why?
|
Aorta | 6 | 2023 | 2041 | 0.490 |
Why?
|
Workload | 2 | 2018 | 844 | 0.490 |
Why?
|
Peritoneum | 1 | 2016 | 225 | 0.480 |
Why?
|
Drug-Eluting Stents | 5 | 2021 | 681 | 0.480 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2017 | 431 | 0.480 |
Why?
|
Research Personnel | 1 | 2019 | 588 | 0.460 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2018 | 474 | 0.450 |
Why?
|
Education, Medical, Graduate | 4 | 2020 | 2373 | 0.450 |
Why?
|
Incidence | 19 | 2022 | 21355 | 0.440 |
Why?
|
Abdomen | 1 | 2019 | 1128 | 0.430 |
Why?
|
Follow-Up Studies | 25 | 2023 | 39107 | 0.420 |
Why?
|
Renin-Angiotensin System | 1 | 2017 | 737 | 0.420 |
Why?
|
New England | 16 | 2018 | 1054 | 0.410 |
Why?
|
Constriction, Pathologic | 6 | 2023 | 1096 | 0.410 |
Why?
|
Defibrillators, Implantable | 1 | 2022 | 1490 | 0.400 |
Why?
|
Anesthesia, General | 4 | 2021 | 1174 | 0.400 |
Why?
|
Laparotomy | 4 | 2018 | 457 | 0.400 |
Why?
|
Treatment Failure | 5 | 2024 | 2644 | 0.390 |
Why?
|
Hematocrit | 3 | 2017 | 623 | 0.390 |
Why?
|
Kidney | 6 | 2024 | 7047 | 0.380 |
Why?
|
Critical Illness | 13 | 2019 | 2723 | 0.380 |
Why?
|
Ultrasonography, Doppler, Duplex | 7 | 2016 | 198 | 0.380 |
Why?
|
Occupational Health | 1 | 2017 | 806 | 0.370 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 1222 | 0.370 |
Why?
|
Patient Admission | 2 | 2021 | 1367 | 0.370 |
Why?
|
Embolectomy | 4 | 2017 | 129 | 0.360 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2017 | 1516 | 0.360 |
Why?
|
Cranial Nerve Injuries | 2 | 2024 | 28 | 0.350 |
Why?
|
Surgery, Computer-Assisted | 1 | 2018 | 1007 | 0.350 |
Why?
|
Embolic Protection Devices | 3 | 2019 | 42 | 0.340 |
Why?
|
Sex Distribution | 3 | 2021 | 2281 | 0.340 |
Why?
|
Body Mass Index | 7 | 2018 | 12954 | 0.340 |
Why?
|
Dyslipidemias | 1 | 2017 | 868 | 0.340 |
Why?
|
Canada | 6 | 2020 | 2122 | 0.330 |
Why?
|
Surgical Wound Infection | 5 | 2019 | 1529 | 0.330 |
Why?
|
Viscera | 1 | 2010 | 138 | 0.330 |
Why?
|
Cost-Benefit Analysis | 6 | 2024 | 5492 | 0.330 |
Why?
|
Collagen Type III | 2 | 2019 | 91 | 0.330 |
Why?
|
Blood Platelets | 1 | 2020 | 2479 | 0.320 |
Why?
|
Thrombosis | 5 | 2021 | 2942 | 0.310 |
Why?
|
Perioperative Period | 4 | 2017 | 250 | 0.310 |
Why?
|
Myocardial Reperfusion Injury | 4 | 2000 | 481 | 0.310 |
Why?
|
Oligosaccharides | 2 | 2000 | 406 | 0.300 |
Why?
|
International Classification of Diseases | 1 | 2013 | 909 | 0.290 |
Why?
|
Intraoperative Complications | 4 | 2020 | 1166 | 0.290 |
Why?
|
Severity of Illness Index | 16 | 2021 | 15843 | 0.290 |
Why?
|
Blood Glucose | 2 | 2018 | 6391 | 0.280 |
Why?
|
Occupational Exposure | 1 | 2017 | 1813 | 0.280 |
Why?
|
Hypertension, Renovascular | 2 | 2024 | 116 | 0.280 |
Why?
|
Coated Materials, Biocompatible | 5 | 2022 | 311 | 0.280 |
Why?
|
Hematoma | 3 | 2018 | 767 | 0.280 |
Why?
|
Brachial Artery | 1 | 2008 | 366 | 0.280 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2018 | 3415 | 0.280 |
Why?
|
Celiac Artery | 3 | 2016 | 65 | 0.270 |
Why?
|
Disease-Free Survival | 10 | 2018 | 6815 | 0.260 |
Why?
|
Lipids | 1 | 2017 | 3341 | 0.260 |
Why?
|
Aspirin | 4 | 2022 | 3133 | 0.260 |
Why?
|
Thinness | 1 | 2009 | 490 | 0.260 |
Why?
|
Advisory Committees | 2 | 2020 | 787 | 0.250 |
Why?
|
Inpatients | 3 | 2020 | 2548 | 0.250 |
Why?
|
Acute Kidney Injury | 4 | 2022 | 1924 | 0.250 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2008 | 292 | 0.250 |
Why?
|
Mortality | 5 | 2021 | 2901 | 0.240 |
Why?
|
Obesity | 4 | 2018 | 12947 | 0.240 |
Why?
|
Prosthesis Failure | 4 | 2021 | 1204 | 0.240 |
Why?
|
Societies, Medical | 7 | 2023 | 3905 | 0.240 |
Why?
|
Hemorrhage | 4 | 2024 | 3424 | 0.230 |
Why?
|
Hypotension | 2 | 2020 | 879 | 0.230 |
Why?
|
Acute Disease | 5 | 2024 | 7237 | 0.230 |
Why?
|
Creatinine | 4 | 2018 | 1899 | 0.230 |
Why?
|
Reproducibility of Results | 9 | 2024 | 20099 | 0.230 |
Why?
|
Loeys-Dietz Syndrome | 1 | 2024 | 40 | 0.230 |
Why?
|
Endothelium, Vascular | 4 | 2006 | 4431 | 0.230 |
Why?
|
American Heart Association | 3 | 2023 | 1039 | 0.220 |
Why?
|
Cost Savings | 3 | 2022 | 913 | 0.220 |
Why?
|
Staphylococcal Infections | 1 | 2013 | 1407 | 0.220 |
Why?
|
Kidney Failure, Chronic | 3 | 2018 | 2472 | 0.220 |
Why?
|
Hemostatic Techniques | 1 | 2024 | 112 | 0.220 |
Why?
|
Iliac Artery | 4 | 2015 | 343 | 0.220 |
Why?
|
Preoperative Care | 5 | 2018 | 2242 | 0.210 |
Why?
|
Ribs | 1 | 2024 | 252 | 0.210 |
Why?
|
Thoracic Outlet Syndrome | 1 | 2024 | 97 | 0.210 |
Why?
|
Mammaplasty | 3 | 2017 | 1239 | 0.210 |
Why?
|
Constriction | 2 | 2019 | 168 | 0.200 |
Why?
|
North America | 3 | 2021 | 1276 | 0.200 |
Why?
|
Off-Label Use | 1 | 2024 | 185 | 0.200 |
Why?
|
Hospitalization | 4 | 2021 | 10721 | 0.200 |
Why?
|
Guideline Adherence | 4 | 2024 | 2220 | 0.200 |
Why?
|
Marfan Syndrome | 1 | 2024 | 236 | 0.200 |
Why?
|
Adult | 34 | 2024 | 221203 | 0.190 |
Why?
|
Cardiology | 2 | 2023 | 1656 | 0.190 |
Why?
|
Microcirculation | 1 | 2006 | 1272 | 0.190 |
Why?
|
Upper Extremity | 2 | 2022 | 658 | 0.190 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 2 | 2022 | 698 | 0.190 |
Why?
|
Technology | 1 | 2023 | 292 | 0.190 |
Why?
|
Clavicle | 1 | 2023 | 224 | 0.190 |
Why?
|
Heart Arrest, Induced | 2 | 2000 | 358 | 0.190 |
Why?
|
Benchmarking | 4 | 2021 | 1045 | 0.180 |
Why?
|
Tibial Arteries | 2 | 2015 | 60 | 0.180 |
Why?
|
Prospective Studies | 18 | 2024 | 54426 | 0.180 |
Why?
|
Disease Progression | 7 | 2018 | 13510 | 0.180 |
Why?
|
Suture Techniques | 2 | 2024 | 769 | 0.180 |
Why?
|
Lung Diseases | 3 | 2021 | 1909 | 0.170 |
Why?
|
Vascular Fistula | 1 | 2020 | 50 | 0.170 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2021 | 231 | 0.170 |
Why?
|
Cohort Studies | 11 | 2023 | 41493 | 0.170 |
Why?
|
Age Distribution | 3 | 2017 | 2880 | 0.170 |
Why?
|
Paraplegia | 1 | 2020 | 161 | 0.170 |
Why?
|
Blood Pressure | 5 | 2024 | 8481 | 0.170 |
Why?
|
Linear Models | 4 | 2018 | 5872 | 0.170 |
Why?
|
Quality-Adjusted Life Years | 3 | 2002 | 1722 | 0.170 |
Why?
|
Personnel Selection | 1 | 2021 | 196 | 0.170 |
Why?
|
Intestinal Fistula | 1 | 2020 | 142 | 0.160 |
Why?
|
Public-Private Sector Partnerships | 1 | 2020 | 122 | 0.160 |
Why?
|
Overweight | 1 | 2010 | 2417 | 0.160 |
Why?
|
Decompression, Surgical | 1 | 2024 | 607 | 0.160 |
Why?
|
Carbon Dioxide | 1 | 2023 | 1147 | 0.160 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2020 | 10212 | 0.160 |
Why?
|
Travel | 1 | 2024 | 796 | 0.150 |
Why?
|
Hernia, Ventral | 2 | 2013 | 218 | 0.150 |
Why?
|
Cultural Competency | 1 | 2021 | 300 | 0.150 |
Why?
|
Remission, Spontaneous | 1 | 2018 | 384 | 0.150 |
Why?
|
Anesthesia, Conduction | 1 | 2021 | 262 | 0.150 |
Why?
|
Life Expectancy | 2 | 2017 | 1242 | 0.150 |
Why?
|
Prisoners | 1 | 2021 | 314 | 0.150 |
Why?
|
Endoscopy | 1 | 2008 | 1851 | 0.150 |
Why?
|
Insurance, Health, Reimbursement | 2 | 2020 | 385 | 0.150 |
Why?
|
Equipment and Supplies | 1 | 2020 | 273 | 0.150 |
Why?
|
Cultural Diversity | 1 | 2021 | 369 | 0.150 |
Why?
|
Ankle Brachial Index | 1 | 2018 | 163 | 0.150 |
Why?
|
Dependent Ambulation | 1 | 2017 | 11 | 0.140 |
Why?
|
Intestines | 2 | 2016 | 1909 | 0.140 |
Why?
|
Body Surface Area | 2 | 2014 | 197 | 0.140 |
Why?
|
Diagnostic Imaging | 3 | 2023 | 3530 | 0.140 |
Why?
|
Health Status | 6 | 2019 | 4077 | 0.140 |
Why?
|
Equipment Design | 3 | 2024 | 3511 | 0.140 |
Why?
|
Thienopyridines | 1 | 2016 | 9 | 0.140 |
Why?
|
Ambulatory Care | 2 | 2021 | 2775 | 0.140 |
Why?
|
Radiation Monitoring | 1 | 2017 | 103 | 0.140 |
Why?
|
Aneurysm, False | 2 | 2020 | 255 | 0.140 |
Why?
|
Prevalence | 4 | 2021 | 15732 | 0.140 |
Why?
|
Housing | 1 | 2021 | 670 | 0.140 |
Why?
|
Contrast Media | 2 | 2023 | 5311 | 0.140 |
Why?
|
Thrombolytic Therapy | 2 | 2024 | 2064 | 0.140 |
Why?
|
Models, Cardiovascular | 2 | 2018 | 981 | 0.140 |
Why?
|
Hyperphosphatemia | 1 | 2016 | 38 | 0.130 |
Why?
|
Heart | 2 | 2019 | 4404 | 0.130 |
Why?
|
Young Adult | 11 | 2024 | 59255 | 0.130 |
Why?
|
Regional Medical Programs | 1 | 2016 | 66 | 0.130 |
Why?
|
Vasodilation | 1 | 2000 | 962 | 0.130 |
Why?
|
Heparin | 1 | 2023 | 1634 | 0.130 |
Why?
|
Cardiovascular Diseases | 3 | 2024 | 15501 | 0.130 |
Why?
|
Watchful Waiting | 2 | 2018 | 491 | 0.130 |
Why?
|
Anesthesia, Local | 1 | 2018 | 277 | 0.130 |
Why?
|
Tubulin Modulators | 3 | 2020 | 107 | 0.130 |
Why?
|
Office Visits | 1 | 2020 | 595 | 0.130 |
Why?
|
Tissue Expansion Devices | 1 | 2016 | 156 | 0.120 |
Why?
|
Physicians, Women | 1 | 2021 | 509 | 0.120 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2018 | 12148 | 0.120 |
Why?
|
Hypothermia, Induced | 1 | 2000 | 753 | 0.120 |
Why?
|
Cardiopulmonary Bypass | 1 | 2000 | 1092 | 0.120 |
Why?
|
New York | 1 | 2017 | 874 | 0.120 |
Why?
|
Minority Groups | 1 | 2022 | 1203 | 0.120 |
Why?
|
Drainage | 1 | 2020 | 1157 | 0.120 |
Why?
|
Clinical Trials as Topic | 2 | 2021 | 8002 | 0.120 |
Why?
|
Rare Diseases | 1 | 2020 | 622 | 0.120 |
Why?
|
Anesthesia, Epidural | 1 | 2016 | 233 | 0.120 |
Why?
|
Hemoglobins | 2 | 2017 | 1526 | 0.120 |
Why?
|
Nerve Block | 1 | 2021 | 706 | 0.110 |
Why?
|
Thrombectomy | 2 | 2016 | 705 | 0.110 |
Why?
|
Consensus | 2 | 2021 | 3123 | 0.110 |
Why?
|
Stroke Volume | 1 | 2007 | 5496 | 0.110 |
Why?
|
Patient Acceptance of Health Care | 1 | 2007 | 3205 | 0.110 |
Why?
|
Europe | 4 | 2020 | 3422 | 0.110 |
Why?
|
Perioperative Care | 2 | 2018 | 1036 | 0.110 |
Why?
|
Secondary Prevention | 1 | 2020 | 1475 | 0.110 |
Why?
|
Metals | 1 | 2018 | 719 | 0.110 |
Why?
|
Operating Rooms | 1 | 2020 | 789 | 0.110 |
Why?
|
Evidence-Based Medicine | 3 | 2023 | 3688 | 0.110 |
Why?
|
Fellowships and Scholarships | 2 | 2012 | 1117 | 0.110 |
Why?
|
Mobility Limitation | 1 | 2017 | 408 | 0.110 |
Why?
|
Phosphates | 1 | 2016 | 770 | 0.100 |
Why?
|
Residence Characteristics | 2 | 2016 | 2094 | 0.100 |
Why?
|
Staphylococcus epidermidis | 1 | 2013 | 123 | 0.100 |
Why?
|
Respiratory Tract Diseases | 1 | 2018 | 750 | 0.100 |
Why?
|
Breast Implants | 1 | 2016 | 411 | 0.100 |
Why?
|
Erythrocyte Transfusion | 1 | 2017 | 570 | 0.100 |
Why?
|
Ticlopidine | 1 | 2017 | 730 | 0.100 |
Why?
|
Tissue Adhesions | 1 | 2013 | 218 | 0.100 |
Why?
|
Hemodynamics | 3 | 2020 | 4160 | 0.100 |
Why?
|
Alloys | 1 | 2012 | 110 | 0.100 |
Why?
|
United States Food and Drug Administration | 1 | 2020 | 1664 | 0.100 |
Why?
|
Renal Insufficiency | 1 | 2017 | 809 | 0.100 |
Why?
|
Ultrasonography | 5 | 2017 | 5972 | 0.100 |
Why?
|
Smoking | 3 | 2018 | 9053 | 0.090 |
Why?
|
Mastectomy | 2 | 2017 | 1822 | 0.090 |
Why?
|
Pre-Eclampsia | 1 | 2020 | 1231 | 0.090 |
Why?
|
Arteriosclerosis | 3 | 2005 | 1055 | 0.090 |
Why?
|
Hospitals, University | 1 | 2013 | 564 | 0.090 |
Why?
|
Body Size | 1 | 2013 | 463 | 0.090 |
Why?
|
Life Style | 2 | 2024 | 3917 | 0.090 |
Why?
|
DNA Mutational Analysis | 1 | 2019 | 4111 | 0.090 |
Why?
|
Pain, Postoperative | 1 | 2021 | 1740 | 0.090 |
Why?
|
Adolescent | 9 | 2024 | 88324 | 0.090 |
Why?
|
Dilatation | 2 | 2022 | 306 | 0.090 |
Why?
|
Sheep | 4 | 2000 | 1440 | 0.090 |
Why?
|
Regional Blood Flow | 3 | 2020 | 1496 | 0.090 |
Why?
|
Internship and Residency | 3 | 2018 | 5882 | 0.090 |
Why?
|
Respiration | 1 | 2016 | 1657 | 0.080 |
Why?
|
Hypertension | 3 | 2024 | 8540 | 0.080 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2017 | 926 | 0.080 |
Why?
|
New Zealand | 2 | 2020 | 358 | 0.080 |
Why?
|
Cerebrovascular Circulation | 1 | 2020 | 2727 | 0.080 |
Why?
|
Models, Theoretical | 1 | 2021 | 3575 | 0.080 |
Why?
|
Life Tables | 3 | 2017 | 364 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2020 | 10766 | 0.080 |
Why?
|
Germany | 2 | 2022 | 875 | 0.080 |
Why?
|
Magnetic Resonance Angiography | 4 | 2019 | 1432 | 0.080 |
Why?
|
Intubation, Intratracheal | 1 | 2016 | 1333 | 0.080 |
Why?
|
Radiography | 3 | 2012 | 6965 | 0.080 |
Why?
|
Cold Temperature | 1 | 2012 | 785 | 0.080 |
Why?
|
Heart Arrest | 1 | 2018 | 1514 | 0.070 |
Why?
|
Anticoagulants | 3 | 2022 | 4812 | 0.070 |
Why?
|
Pain | 1 | 2023 | 5073 | 0.070 |
Why?
|
Delirium | 1 | 2019 | 1668 | 0.070 |
Why?
|
Terminology as Topic | 1 | 2015 | 1530 | 0.070 |
Why?
|
Surgical Flaps | 1 | 2016 | 1671 | 0.070 |
Why?
|
Attitude of Health Personnel | 1 | 2021 | 3889 | 0.070 |
Why?
|
Survivors | 1 | 2018 | 2371 | 0.070 |
Why?
|
Prognosis | 4 | 2022 | 29629 | 0.070 |
Why?
|
England | 2 | 2020 | 526 | 0.070 |
Why?
|
Health Services Accessibility | 2 | 2024 | 5440 | 0.070 |
Why?
|
Forecasting | 1 | 2016 | 2928 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 4 | 2014 | 20571 | 0.070 |
Why?
|
Intestinal Obstruction | 1 | 2010 | 432 | 0.070 |
Why?
|
Dilatation, Pathologic | 2 | 2022 | 527 | 0.070 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2021 | 4016 | 0.070 |
Why?
|
Netherlands | 2 | 2024 | 2221 | 0.070 |
Why?
|
Lymphocytes | 1 | 2014 | 2612 | 0.070 |
Why?
|
Atherosclerosis | 2 | 2014 | 3408 | 0.070 |
Why?
|
Medication Adherence | 1 | 2018 | 2176 | 0.070 |
Why?
|
Animals, Newborn | 3 | 2000 | 2677 | 0.070 |
Why?
|
Breast Neoplasms | 3 | 2017 | 21017 | 0.060 |
Why?
|
Cause of Death | 3 | 2020 | 3683 | 0.060 |
Why?
|
Internationality | 2 | 2021 | 1001 | 0.060 |
Why?
|
Population Surveillance | 2 | 2020 | 2598 | 0.060 |
Why?
|
Massachusetts | 2 | 2019 | 8830 | 0.060 |
Why?
|
Subclavian Vein | 1 | 2024 | 57 | 0.060 |
Why?
|
Mesentery | 1 | 2005 | 202 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 2 | 2024 | 17904 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3429 | 0.060 |
Why?
|
Biocompatible Materials | 1 | 2012 | 1685 | 0.060 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2850 | 0.050 |
Why?
|
Atherectomy | 1 | 2023 | 42 | 0.050 |
Why?
|
Primary Health Care | 1 | 2020 | 4686 | 0.050 |
Why?
|
Transplantation, Autologous | 2 | 2019 | 2115 | 0.050 |
Why?
|
Censuses | 1 | 2024 | 202 | 0.050 |
Why?
|
Laparoscopy | 1 | 2015 | 2036 | 0.050 |
Why?
|
Reference Values | 2 | 2021 | 4920 | 0.050 |
Why?
|
Quality of Health Care | 1 | 2018 | 4330 | 0.050 |
Why?
|
Hypercholesterolemia | 1 | 2009 | 1141 | 0.050 |
Why?
|
Gastroesophageal Reflux | 1 | 2009 | 819 | 0.050 |
Why?
|
Research Design | 3 | 2017 | 6180 | 0.050 |
Why?
|
Gold | 1 | 2005 | 482 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2013 | 8528 | 0.050 |
Why?
|
Algorithms | 1 | 2022 | 14032 | 0.050 |
Why?
|
Foot | 1 | 2004 | 575 | 0.040 |
Why?
|
State Medicine | 1 | 2022 | 216 | 0.040 |
Why?
|
Survival Analysis | 5 | 2013 | 10090 | 0.040 |
Why?
|
Hungary | 1 | 2020 | 82 | 0.040 |
Why?
|
Nitroprusside | 1 | 2000 | 272 | 0.040 |
Why?
|
Research Report | 1 | 2022 | 367 | 0.040 |
Why?
|
Decision Trees | 1 | 2021 | 504 | 0.040 |
Why?
|
Foreign-Body Migration | 1 | 2021 | 219 | 0.040 |
Why?
|
Singapore | 1 | 2020 | 292 | 0.040 |
Why?
|
Ulcer | 1 | 2020 | 204 | 0.040 |
Why?
|
Osteotomy | 1 | 2024 | 837 | 0.040 |
Why?
|
Dissection | 1 | 2020 | 298 | 0.040 |
Why?
|
Lumbar Vertebrae | 1 | 2008 | 1879 | 0.040 |
Why?
|
Femoral Vein | 1 | 2019 | 153 | 0.040 |
Why?
|
Finland | 1 | 2020 | 607 | 0.040 |
Why?
|
Norway | 1 | 2020 | 499 | 0.040 |
Why?
|
Spinal Fusion | 1 | 2008 | 1286 | 0.040 |
Why?
|
Drug Administration Schedule | 2 | 2017 | 4853 | 0.040 |
Why?
|
Multilevel Analysis | 1 | 2018 | 150 | 0.040 |
Why?
|
Pressure | 1 | 2001 | 1154 | 0.040 |
Why?
|
Delphi Technique | 1 | 2022 | 846 | 0.040 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2005 | 1725 | 0.040 |
Why?
|
Acetylcholine | 1 | 2000 | 629 | 0.040 |
Why?
|
Kidney Transplantation | 1 | 2013 | 4235 | 0.040 |
Why?
|
Polytetrafluoroethylene | 1 | 2019 | 245 | 0.040 |
Why?
|
Coma | 1 | 2022 | 484 | 0.040 |
Why?
|
After-Hours Care | 1 | 2018 | 102 | 0.040 |
Why?
|
Lung | 1 | 2016 | 10002 | 0.040 |
Why?
|
Neutrophils | 2 | 2000 | 3767 | 0.040 |
Why?
|
Denmark | 1 | 2020 | 771 | 0.040 |
Why?
|
Pulmonary Circulation | 1 | 2000 | 737 | 0.040 |
Why?
|
Analysis of Variance | 2 | 2010 | 6228 | 0.040 |
Why?
|
Physical Examination | 1 | 2023 | 1255 | 0.040 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2021 | 621 | 0.040 |
Why?
|
Recovery of Function | 2 | 2021 | 2979 | 0.040 |
Why?
|
Italy | 1 | 2019 | 842 | 0.040 |
Why?
|
Universities | 1 | 2022 | 993 | 0.040 |
Why?
|
Cerebrovascular Disorders | 2 | 2015 | 1474 | 0.040 |
Why?
|
Peroxidase | 1 | 2000 | 609 | 0.040 |
Why?
|
Colectomy | 1 | 2022 | 688 | 0.030 |
Why?
|
Health Care Surveys | 1 | 2024 | 2426 | 0.030 |
Why?
|
Sweden | 1 | 2020 | 1379 | 0.030 |
Why?
|
Australia | 1 | 2020 | 1250 | 0.030 |
Why?
|
Selectins | 1 | 1996 | 101 | 0.030 |
Why?
|
Renal Replacement Therapy | 1 | 2018 | 282 | 0.030 |
Why?
|
Markov Chains | 1 | 2000 | 966 | 0.030 |
Why?
|
Anastomosis, Surgical | 1 | 2020 | 983 | 0.030 |
Why?
|
Pregnancy | 3 | 2023 | 29876 | 0.030 |
Why?
|
Vasodilator Agents | 1 | 2000 | 973 | 0.030 |
Why?
|
Comparative Effectiveness Research | 1 | 2021 | 709 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2000 | 1682 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2024 | 26127 | 0.030 |
Why?
|
Surgical Wound Dehiscence | 1 | 2016 | 212 | 0.030 |
Why?
|
Myocardial Reperfusion | 1 | 1996 | 338 | 0.030 |
Why?
|
Myocardial Contraction | 1 | 2000 | 1515 | 0.030 |
Why?
|
Diabetes Complications | 2 | 2015 | 1315 | 0.030 |
Why?
|
Organ Size | 1 | 2020 | 2254 | 0.030 |
Why?
|
Mutation | 1 | 2019 | 30054 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2020 | 5247 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2020 | 1440 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2024 | 2024 | 0.030 |
Why?
|
Breast Implantation | 1 | 2017 | 223 | 0.030 |
Why?
|
Inflammation | 1 | 2014 | 10773 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2020 | 909 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12975 | 0.030 |
Why?
|
Animals | 5 | 2019 | 168467 | 0.030 |
Why?
|
Postpartum Period | 1 | 2020 | 1173 | 0.030 |
Why?
|
Cell Adhesion | 1 | 2000 | 3088 | 0.030 |
Why?
|
International Cooperation | 1 | 2020 | 1422 | 0.030 |
Why?
|
Syndrome | 1 | 2019 | 3267 | 0.030 |
Why?
|
Models, Economic | 1 | 2017 | 716 | 0.030 |
Why?
|
Preoperative Period | 1 | 2015 | 551 | 0.030 |
Why?
|
Antibiotic Prophylaxis | 1 | 2018 | 637 | 0.030 |
Why?
|
Mechanics | 1 | 2012 | 15 | 0.030 |
Why?
|
Fibrinolytic Agents | 1 | 2022 | 2084 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 2018 | 1668 | 0.020 |
Why?
|
Regression Analysis | 1 | 2021 | 6344 | 0.020 |
Why?
|
Pain Measurement | 1 | 2021 | 3551 | 0.020 |
Why?
|
Postoperative Period | 1 | 2015 | 1814 | 0.020 |
Why?
|
Models, Biological | 1 | 2006 | 9469 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2016 | 1386 | 0.020 |
Why?
|
Polysaccharides | 1 | 1996 | 1014 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2019 | 2571 | 0.020 |
Why?
|
Area Under Curve | 1 | 2013 | 1638 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2016 | 1836 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2015 | 931 | 0.020 |
Why?
|
Coronary Vessels | 1 | 2000 | 3096 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2017 | 3597 | 0.020 |
Why?
|
Hemostasis, Surgical | 1 | 2008 | 126 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2015 | 1505 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2018 | 2759 | 0.020 |
Why?
|
Nursing Homes | 1 | 2015 | 1082 | 0.020 |
Why?
|
Up-Regulation | 1 | 2016 | 4124 | 0.020 |
Why?
|
Body Height | 1 | 2013 | 1570 | 0.020 |
Why?
|
Echocardiography | 1 | 2019 | 4989 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6312 | 0.020 |
Why?
|
Genetic Testing | 1 | 2019 | 3537 | 0.020 |
Why?
|
Mesenteric Artery, Inferior | 1 | 2005 | 15 | 0.020 |
Why?
|
Stainless Steel | 1 | 2005 | 79 | 0.020 |
Why?
|
Curriculum | 1 | 2018 | 3743 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2021 | 3808 | 0.010 |
Why?
|
Probability | 1 | 2010 | 2477 | 0.010 |
Why?
|
New Hampshire | 1 | 2004 | 175 | 0.010 |
Why?
|
Device Approval | 1 | 2006 | 163 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2017 | 3249 | 0.010 |
Why?
|
Computer Simulation | 1 | 2017 | 6241 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2017 | 7827 | 0.010 |
Why?
|
Body Weight | 1 | 2013 | 4618 | 0.010 |
Why?
|
Heart Diseases | 1 | 2016 | 2781 | 0.010 |
Why?
|
Communication | 1 | 2017 | 3873 | 0.010 |
Why?
|
Ventricular Function, Left | 1 | 1995 | 3879 | 0.010 |
Why?
|
Tomography, Spiral Computed | 1 | 2003 | 273 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2016 | 11121 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16592 | 0.010 |
Why?
|
ROC Curve | 1 | 2009 | 3579 | 0.010 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 3204 | 0.010 |
Why?
|
Coronary Circulation | 2 | 1996 | 1569 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2003 | 1574 | 0.010 |
Why?
|
Heart Failure | 2 | 2015 | 11670 | 0.010 |
Why?
|
Blood Flow Velocity | 1 | 2002 | 1371 | 0.010 |
Why?
|
Intraoperative Care | 1 | 2002 | 767 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2016 | 5336 | 0.010 |
Why?
|
Observer Variation | 1 | 2004 | 2606 | 0.010 |
Why?
|
Brain | 1 | 2004 | 27120 | 0.010 |
Why?
|
Infant | 1 | 2019 | 36192 | 0.010 |
Why?
|
Nutritional Status | 1 | 2005 | 1615 | 0.010 |
Why?
|
Aging | 1 | 1995 | 8711 | 0.010 |
Why?
|
Child, Preschool | 1 | 2019 | 42230 | 0.010 |
Why?
|
Hypothermia | 1 | 1995 | 188 | 0.010 |
Why?
|
Leukocyte Count | 1 | 1996 | 1596 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 1996 | 1334 | 0.010 |
Why?
|
Child | 1 | 2019 | 80156 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 1996 | 1866 | 0.010 |
Why?
|
Software | 1 | 2003 | 4434 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2002 | 14666 | 0.000 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2003 | 9002 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 1996 | 18253 | 0.000 |
Why?
|